en
Scientific article
English

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

ContributorsEuropean Union HCV collaborators
CollaboratorsNegro, Francesco
Published inThe Lancet Gastroenterology & Hepatology, vol. 2, no. 5, p. 325-336
Publication date2017
Abstract

Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a 65% reduction in liver-related deaths, a 90% reduction of new viral hepatitis infections, and 90% of patients with viral hepatitis infections being diagnosed by 2030. This study assessed the prevalence of HCV in the EU and the level of intervention required to achieve WHO targets for HCV elimination.

Keywords
  • Antiviral Agents/therapeutic use
  • Cost of Illness
  • Disease Eradication
  • Emigration and Immigration/statistics & numerical data
  • European Union
  • Hepatitis C/diagnosis/drug therapy/epidemiology/prevention & control
  • Humans
  • Markov Chains
  • Prevalence
  • Viremia/diagnosis/drug therapy/epidemiology/prevention & control
  • World Health Organization
Citation (ISO format)
European Union HCV collaborators. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study. In: The Lancet Gastroenterology & Hepatology, 2017, vol. 2, n° 5, p. 325–336. doi: 10.1016/S2468-1253(17)30045-6
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2468-1253
239views
0downloads

Technical informations

Creation11/08/2019 3:41:00 PM
First validation11/08/2019 3:41:00 PM
Update time03/15/2023 6:19:45 PM
Status update03/15/2023 6:19:45 PM
Last indexation01/17/2024 6:45:47 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack